Company intelligence / Profile preview

Mindpax

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Mindpax has developed a clinically validated digital therapeutic system for bipolar disorder that combines long-term symptom monitoring with targeted psychoeducation. The company has conducted the largest worldwide clinical data set of its kind in bipolar patients over five years. Their algorithms are being validated in ongoing studies with promising results published in medical journals. The solution enables real-time remote assessment and personalized intervention to improve patient outcomes.

Therapeutic areas: Psychiatry
Modalities: DeviceNon-pharmacological therapy (Digital therapeutics delivered via mobile and web platforms, focused on behavioral interventions and monitoring)
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

Mindpax digital therapeutic

Commercial

Indications: Bipolar disorder, Schizophrenia, Major depressive disorder

Partnerships

EVERSANA (U.S. commercialization partner)

Beyond the preview

Go deeper on Mindpax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mindpax.

Explore the full profile